The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 15, 2018

Filed:

Feb. 06, 2015
Applicant:

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Benjamin D. Humphreys, Brookline, MA (US);

Rafael Kramann, Lemiers, NL;

Derek Dirocco, Brookline, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); G01N 33/569 (2006.01); C12N 5/0775 (2010.01); G01N 33/68 (2006.01); A61K 38/06 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56966 (2013.01); A61K 38/063 (2013.01); C12N 5/0668 (2013.01); G01N 33/5023 (2013.01); G01N 33/6887 (2013.01); G01N 2333/4703 (2013.01); G01N 2333/4712 (2013.01); G01N 2800/085 (2013.01); G01N 2800/347 (2013.01);
Abstract

Methods are provided herein for the use of Gli-1 as a specific marker for myofibroblast progenitor cells, thereby permitting the diagnosis of early stages of fibrosis prior to the onset of organ failure. Also provided herein are methods of isolating Gli-1+ cells for e.g., use in high-throughput screening of compounds for the treatment or prevention of fibrosis. In another aspect, provided herein are methods of treating or preventing fibrosis (e.g., kidney fibrosis) in a subject by administering a Gli inhibitor, particularly a Gli-2 inhibitor or a Gli-1/Gli-2 inhibitor.


Find Patent Forward Citations

Loading…